ID   CD81_RAT                Reviewed;         236 AA.
AC   Q62745;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   08-NOV-2023, entry version 151.
DE   RecName: Full=CD81 antigen;
DE   AltName: Full=26 kDa cell surface protein TAPA-1;
DE   AltName: Full=Target of the antiproliferative antibody 1;
DE   AltName: CD_antigen=CD81;
GN   Name=Cd81; Synonyms=Tapa1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Brain cortex;
RX   PubMed=8757260; DOI=10.1523/jneurosci.16-17-05478.1996;
RA   Geisert E.E. Jr., Yang L., Irwin M.H.;
RT   "Astrocyte growth, reactivity, and the target of the antiproliferative
RT   antibody, TAPA.";
RL   J. Neurosci. 16:5478-5487(1996).
RN   [2]
RP   PROTEIN SEQUENCE OF 125-144; 172-187 AND 194-201, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RA   Lubec G., Kang S.U., Lubec S.;
RL   Submitted (SEP-2007) to UniProtKB.
CC   -!- FUNCTION: Structural component of specialized membrane microdomains
CC       known as tetraspanin-enriched microdomains (TERMs), which act as
CC       platforms for receptor clustering and signaling. Essential for
CC       trafficking and compartmentalization of CD19 receptor on the surface of
CC       activated B cells. Upon initial encounter with microbial pathogens,
CC       enables the assembly of CD19-CR2/CD21 and B cell receptor (BCR)
CC       complexes at signaling TERMs, lowering the threshold dose of antigen
CC       required to trigger B cell clonal expansion and antibody production. In
CC       T cells, facilitates the localization of CD247/CD3 zeta at antigen-
CC       induced synapses with B cells, providing for costimulation and
CC       polarization toward T helper type 2 phenotype. Present in MHC class II
CC       compartments, may also play a role in antigen presentation (By
CC       similarity). Can act both as positive and negative regulator of
CC       homotypic or heterotypic cell-cell fusion processes. Positively
CC       regulates sperm-egg fusion and may be involved in acrosome reaction. In
CC       myoblasts, associates with CD9 and PTGFRN and inhibits myotube fusion
CC       during muscle regeneration (By similarity). In macrophages, associates
CC       with CD9 and beta-1 and beta-2 integrins, and prevents macrophage
CC       fusion into multinucleated giant cells specialized in ingesting
CC       complement-opsonized large particles (By similarity). Also prevents the
CC       fusion of mononuclear cell progenitors into osteoclasts in charge of
CC       bone resorption (By similarity). May regulate the compartmentalization
CC       of enzymatic activities. In T cells, defines the subcellular
CC       localization of dNTPase SAMHD1 and permits its degradation by the
CC       proteasome, thereby controlling intracellular dNTP levels (By
CC       similarity). Also involved in cell adhesion and motility. Positively
CC       regulates integrin-mediated adhesion of macrophages, particularly
CC       relevant for the inflammatory response in the lung (By similarity).
CC       {ECO:0000250|UniProtKB:P35762, ECO:0000250|UniProtKB:P60033}.
CC   -!- SUBUNIT: Homodimer. Part of a complex composed of CD19, CR2/CD21, CD81
CC       and IFITM1/CD225 in the membrane of mature B cells. Interacts (via the
CC       second extracellular domain) with CD19; this interaction is initiated
CC       early during biosynthesis in the ER and enables trafficking of only
CC       properly folded CD19. Part of a complex that includes MHC class II/HLA-
CC       DR molecules and IFITM1. Interacts with IFITM1 (By similarity).
CC       Interacts with IFITM2 and IFITM3 (By similarity). Part of integrin-
CC       tetraspanin complex composed of CD9, CD81, beta-1 and beta-2 integrins
CC       in the membrane of monocyte/macrophages. Interacts (via the second
CC       extracellular domain) with integrin ITGAV:ITGB3. Interacts with
CC       CD247/CD3 zeta, ICAM1 and CD9 at the immune synapse on T cell membrane
CC       (By similarity). Part of a GPCR-tetraspanin complex consisting at least
CC       of ADGRG1, CD81, possibly CD9, and GNA11 in which CD81 enhances the
CC       association of ADGRG1 with GNA11. Part of a complex composed of CD9,
CC       CD81, PTGFRN and IGSF8 (By similarity). Interacts directly with IGSF8.
CC       Interacts with CD53 and SCIMP. Interacts with SAMHD1 (via its C-
CC       terminus) (By similarity). Interacts with glypican GPC3 and with the
CC       transcriptional repressor HHEX; binding to GPC3 decreases the
CC       availability of free CD81 for binding to HHEX, resulting in nuclear
CC       translocation of HHEX and transcriptional repression (By similarity).
CC       Interacts with CLDN1. Interacts with CLDN6 and CLDN9 (By similarity).
CC       {ECO:0000250|UniProtKB:P35762, ECO:0000250|UniProtKB:P60033}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:P35762};
CC       Multi-pass membrane protein {ECO:0000255}. Basolateral cell membrane
CC       {ECO:0000250|UniProtKB:P60033}; Multi-pass membrane protein
CC       {ECO:0000255}. Note=Associates with CLDN1 and the CLDN1-CD81 complex
CC       localizes to the basolateral cell membrane.
CC       {ECO:0000250|UniProtKB:P60033}.
CC   -!- DOMAIN: Binds cholesterol in a cavity lined by the transmembrane spans.
CC       {ECO:0000250|UniProtKB:P60033}.
CC   -!- PTM: Not glycosylated. {ECO:0000305}.
CC   -!- PTM: Likely constitutively palmitoylated at low levels. Protein
CC       palmitoylation is up-regulated upon coligation of BCR and CD9-C2R-CD81
CC       complexes in lipid rafts. {ECO:0000250|UniProtKB:P60033}.
CC   -!- SIMILARITY: Belongs to the tetraspanin (TM4SF) family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U19894; AAC53103.1; -; mRNA.
DR   AlphaFoldDB; Q62745; -.
DR   SMR; Q62745; -.
DR   BioGRID; 247650; 1.
DR   STRING; 10116.ENSRNOP00000027760; -.
DR   iPTMnet; Q62745; -.
DR   PhosphoSitePlus; Q62745; -.
DR   SwissPalm; Q62745; -.
DR   PaxDb; 10116-ENSRNOP00000027760; -.
DR   UCSC; RGD:2315; rat.
DR   AGR; RGD:2315; -.
DR   RGD; 2315; Cd81.
DR   eggNOG; KOG3882; Eukaryota.
DR   InParanoid; Q62745; -.
DR   PhylomeDB; Q62745; -.
DR   Reactome; R-RNO-198933; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell.
DR   Reactome; R-RNO-977606; Regulation of Complement cascade.
DR   PRO; PR:Q62745; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:RGD.
DR   GO; GO:0009925; C:basal plasma membrane; ISO:RGD.
DR   GO; GO:0016323; C:basolateral plasma membrane; ISO:RGD.
DR   GO; GO:0070062; C:extracellular exosome; ISO:RGD.
DR   GO; GO:0001772; C:immunological synapse; ISS:UniProtKB.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0097197; C:tetraspanin-enriched microdomain; ISS:UniProtKB.
DR   GO; GO:0031982; C:vesicle; ISO:RGD.
DR   GO; GO:0015485; F:cholesterol binding; ISS:UniProtKB.
DR   GO; GO:0005178; F:integrin binding; ISS:UniProtKB.
DR   GO; GO:0042289; F:MHC class II protein binding; ISO:RGD.
DR   GO; GO:1990459; F:transferrin receptor binding; ISO:RGD.
DR   GO; GO:0001618; F:virus receptor activity; ISO:RGD.
DR   GO; GO:0035783; P:CD4-positive, alpha-beta T cell costimulation; ISS:UniProtKB.
DR   GO; GO:0071404; P:cellular response to low-density lipoprotein particle stimulus; ISS:UniProtKB.
DR   GO; GO:0002455; P:humoral immune response mediated by circulating immunoglobulin; ISS:UniProtKB.
DR   GO; GO:0001771; P:immunological synapse formation; ISS:UniProtKB.
DR   GO; GO:0034238; P:macrophage fusion; ISS:UniProtKB.
DR   GO; GO:0014905; P:myoblast fusion involved in skeletal muscle regeneration; ISS:UniProtKB.
DR   GO; GO:0072675; P:osteoclast fusion; ISS:UniProtKB.
DR   GO; GO:1905676; P:positive regulation of adaptive immune memory response; ISO:RGD.
DR   GO; GO:0050871; P:positive regulation of B cell activation; ISS:UniProtKB.
DR   GO; GO:0030890; P:positive regulation of B cell proliferation; ISO:RGD.
DR   GO; GO:0050861; P:positive regulation of B cell receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:2000563; P:positive regulation of CD4-positive, alpha-beta T cell proliferation; ISS:UniProtKB.
DR   GO; GO:0002863; P:positive regulation of inflammatory response to antigenic stimulus; ISS:UniProtKB.
DR   GO; GO:0043410; P:positive regulation of MAPK cascade; ISS:UniProtKB.
DR   GO; GO:1904352; P:positive regulation of protein catabolic process in the vacuole; ISO:RGD.
DR   GO; GO:0070863; P:positive regulation of protein exit from endoplasmic reticulum; ISS:UniProtKB.
DR   GO; GO:1903911; P:positive regulation of receptor clustering; ISS:UniProtKB.
DR   GO; GO:2001190; P:positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell; ISS:UniProtKB.
DR   GO; GO:0050862; P:positive regulation of T cell receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:2000553; P:positive regulation of T-helper 2 cell cytokine production; ISS:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0061462; P:protein localization to lysosome; ISO:RGD.
DR   GO; GO:0072659; P:protein localization to plasma membrane; ISS:UniProtKB.
DR   GO; GO:0031623; P:receptor internalization; ISS:UniProtKB.
DR   GO; GO:2000145; P:regulation of cell motility; ISO:RGD.
DR   GO; GO:0042127; P:regulation of cell population proliferation; IDA:RGD.
DR   GO; GO:0040008; P:regulation of growth; IEP:RGD.
DR   GO; GO:1905521; P:regulation of macrophage migration; ISS:UniProtKB.
DR   GO; GO:0031647; P:regulation of protein stability; ISO:RGD.
DR   CDD; cd03151; CD81_like_LEL; 1.
DR   Gene3D; 1.10.1450.10; Tetraspanin; 1.
DR   InterPro; IPR018499; Tetraspanin/Peripherin.
DR   InterPro; IPR000301; Tetraspanin_animals.
DR   InterPro; IPR018503; Tetraspanin_CS.
DR   InterPro; IPR008952; Tetraspanin_EC2_sf.
DR   PANTHER; PTHR19282:SF214; CD81 ANTIGEN; 1.
DR   PANTHER; PTHR19282; TETRASPANIN; 1.
DR   Pfam; PF00335; Tetraspanin; 1.
DR   PIRSF; PIRSF002419; Tetraspanin; 1.
DR   PRINTS; PR00259; TMFOUR.
DR   SUPFAM; SSF48652; Tetraspanin; 1.
DR   PROSITE; PS00421; TM4_1; 1.
PE   1: Evidence at protein level;
KW   Adaptive immunity; Cell membrane; Direct protein sequencing;
KW   Disulfide bond; Immunity; Lipid-binding; Membrane; Reference proteome;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN           1..236
FT                   /note="CD81 antigen"
FT                   /id="PRO_0000219224"
FT   TOPO_DOM        1..12
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        13..33
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:P60033"
FT   TOPO_DOM        34..63
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        64..84
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:P60033"
FT   TOPO_DOM        85..89
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        90..112
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:P60033"
FT   TOPO_DOM        113..201
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        202..224
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:P60033"
FT   TOPO_DOM        225..236
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   BINDING         219
FT                   /ligand="cholesterol"
FT                   /ligand_id="ChEBI:CHEBI:16113"
FT                   /evidence="ECO:0000250|UniProtKB:P60033"
FT   SITE            116
FT                   /note="Important for interaction with integrin"
FT                   /evidence="ECO:0000250|UniProtKB:P60033"
FT   SITE            144
FT                   /note="Important for interaction with integrin"
FT                   /evidence="ECO:0000250|UniProtKB:P60033"
FT   SITE            148
FT                   /note="Important for interaction with integrin"
FT                   /evidence="ECO:0000250|UniProtKB:P60033"
FT   DISULFID        156..190
FT                   /evidence="ECO:0000250|UniProtKB:P60033"
FT   DISULFID        157..175
FT                   /evidence="ECO:0000250|UniProtKB:P60033"
SQ   SEQUENCE   236 AA;  25889 MW;  DCC48F38EB19BDF5 CRC64;
     MGVEGCTKCI KYLLFVFNFV FWLAGGVILG VALWLRHDPQ TTTLLYLELG DKPAPSTFYV
     GIYILIAVGA VMMFVGFLGC YGAIQESQCL LGTFFTCLVI LFACEVAAGI WGFVNKDQIA
     KDVKQFYDQA LQQAVMDDDA NNAKAVVKTF HETLNCCGSN TLTTLTTAVL RNSLCPSSSN
     SFTQLLKEDC HQKIDELFSG KLYLIGIAAI VVAVIMIFEM ILSMVLCCGI RNSSVY
//
